Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2012-11-30 01:30TTY Biopharm Opens $100 Million Manufacturing Plant in Suzhou and more...
2012-11-29 01:30Chi-Med and Nestlé Form JV to Develop Chi-Med's Lead Drug Candidate
2012-11-28 01:30Crown Bioscience and Beijing Purunao Team Up to Develop Cancer Drugs and more...
2012-11-27 01:30Stake in China Pharma R&D Center Co. Up for Sale
2012-11-25 01:30Week in Review: Henan Province Starts $40 Million Biological Fund
2012-11-24 01:30Hua Medicine Advances Diabetes Treatment toward Trial
2012-11-22 01:30iHuman Institute at Shanghai Tech to Study Cell Signaling
2012-11-21 01:30Sihuan Pharma In-Licenses Two CCV Products from NeuroVive of Sweden
2012-11-20 01:30Changshan Pharma and ConjuChem Form $3 Million Diabetes JV and more...
2012-11-18 01:30Week in Review: PerkinElmer Buys Haoyuan Biotech, a Diagnostics Company
2012-11-17 01:30Innovent Biologics Raises $25 Million for Suzhou cGMP Facility and more...
2012-11-16 01:30Promega Opens Manufacturing Facility in Shanghai
2012-11-15 01:30In China, Roche and Swiss Re Offer Insurance to Cover Biologic Drugs and more...
2012-11-14 01:30PerkinElmer Buys Haoyuan Biotech, a Diagnostics Company, for $38 Million
2012-11-13 01:30India's Orchid Chemicals and Pharma Quits its China Antibiotic JV and more...
2012-11-11 01:30Week in Review: Vivo Ventures Leads $30 Million Funding of Jingfeng Pharma
2012-11-10 01:30Sinopharm is in M&A Discussions with Foreign Pharmas and more...
2012-11-09 01:30Akeso Biopharma, a China Antibody Company, Opens in Zhongshan
2012-11-08 01:30Mindray Medical's Q3 Financial Report Disappoints
2012-11-07 01:30Zhongyuan Union to Set Up Stem Cell JV with Cell Therapy of the UK
2012-11-06 01:30Vivo Ventures Leads $30 Million Funding of Shanghai Jingfeng Pharma and more...
2012-11-04 01:30Week in Review: Charles River Labs Buys China's Vital River
2012-11-03 01:30Hutchison MediPharma Starts Clinical Trial on Fourth Cancer Drug
2012-11-02 01:30Innovent Constructing Biologic Facility in Suzhou and more...
2012-11-01 01:30SLG-Giant Pharm, a China CRO, to Run China Arm of US NIH Trial

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC